Dr. Joana Pantoja, OD accepts new patients on Medical News Today.
Dr. Joana Pantoja, OD
Be the first to review this provider!
Oklahoma City, OK
Accepting new patients
Clinical Overview
Dr. Joana Pantoja, OD works in Oklahoma City, OK as
Office Locations
-
Samuel C. Oliphant Inc14000 Quailbrook Dr, Oklahoma City, OK 73134
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Dr. Pantoja?
Step 1 of 3
Your review of Dr. Joana Pantoja, OD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Optometry
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Dr. Pantoja's office is located at 14000 Quailbrook Dr Oklahoma City, OK 73134. Get a map and directions to Dr. Pantoja's office here.
Dr. Pantoja does not have any reviews yet.
Claim Your Profile
Are you Dr. Joana Pantoja, OD?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
A recent study has found that higher glycoprotein acetyls (GlycA) levels, a marker of inflammation, are linked with an increased risk of heart problems, including heart attack, heart failure, and stroke.
According to a recent review, cefepime was associated with increased mortality compared with other β-lactam antibiotics. Cefepime is used for the treatment of conditions such as pneumonia and bacterial meningitis.
A new analysis including 51 prospective cohort studies and more than 8.8 million participants has highlighted an association between higher consumption of ultra-processed foods and a higher risk of multiple health conditions.
